FDA.reportPublic FDA data

lenvatinib 4 MG Oral Capsule

RxCUI
1604348
RxNorm name
lenvatinib 4 MG Oral Capsule
Display name
lenvatinib 4 MG Oral Capsule
Full name
lenvatinib 4 MG Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f4bedd21-efde-44c6-9d9c-b48b78d7ed1elenvatinib 4 MG Oral Capsule [PSN] · lenvatinib 4 MG Oral Capsule [SCD] · lenvatinib 4 MG (as lenvatinib mesylate 4.9 MG) Oral Capsule [SY]378These highlights do not include all the information needed to use LENVIMA safely and effectively. See full prescribing information for LENVIMA . LENVIMA ® ( lenvatinib ) capsules , for oral use Initial U.S. Approval: 201520250103